OptimizeRx (OPRX) Revenue (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Revenue data on file, last reported at $19.8 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 9.5% year-over-year to $19.8 million; the trailing twelve-month figure through Mar 2026 stood at $107.3 million (up 13.76% YoY), and the FY2025 full-year result was $109.4 million, up 18.78% from the prior year.
• Revenue eased to $19.8 million in Q1 2026, from $32.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $32.3 million in Q4 2024 to a low of $13.0 million in Q1 2023.
• A 5-year average of $20.9 million and a median of $19.7 million in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 55.19% in 2025 and retreated 9.5% in 2026, its largest moves.
• Tracing OPRX's Revenue over 5 years: stood at $19.7 million in 2022, then jumped by 44.34% to $28.4 million in 2023, then rose by 13.91% to $32.3 million in 2024, then declined by 0.24% to $32.2 million in 2025, then sank by 38.45% to $19.8 million in 2026.
• Business Quant data shows OPRX's Revenue at $19.8 million in Q1 2026, $32.2 million in Q4 2025, and $26.1 million in Q3 2025.